Pfizer
Respiratory syncytial virus and the race for a vaccine
November 21 by Leila HawkinsAs cases of RSV surge vaccine manufacturers are racing to find a treatment
Top 10 vaccine manufacturers worldwide
October 21 by Leila HawkinsPharma IQ lists the 10 biggest vaccine manufacturers in the world
First-ever injectable HIV prevention drug to be produced generically
July 28 by Leila HawkinsGeneric versions of new HIV prevention drug to be produced in low and lower-middle income regions
New Covid-19 vaccines show high immunity against Omicron
June 27 by Leila HawkinsPharma companies release successful results for vaccines targeting Omicron
The top 10 pharma companies on the 2022 Fortune 500 list
May 27 by Leila HawkinsWe look at the top 10 pharmaceutical companies on the Fortune 500 list this year
Keeping tabs on pharma: Clinical trials on pause in Russia
March 16 by Leila HawkinsIn Pharma IQ’s latest news round-up: Clinical trials pause in Russia but medical supplies will continue
2022 State of Digital Lab Transformation in Biopharma
December 24 by Ben WattsPharma IQ's industry-wide survey reveals the latest digital lab trends, including FAIR data adoption, AI/ML for scientific research and cloud utilization in biopharma R&D
Keeping tabs on Covid-19: battling Omicron, Merck’s antiviral
December 09 by Leila HawkinsAs the world grapples with another Covid-19 variant, BioNTech and Pfizer announce it can be neutralized with three vaccinations, while new antiviral pills provide hope
Addressing pharma’s need to focus on continuous manufacturing
November 25 by Pharma IQPfizer’s Juan Colberg discusses continuous manufacturing pain points and strategies ahead of his session at Pharma IQ Live: Continuous Processing 2021
Keeping tabs on pharma: Big pharma makes progress on ‘difficult-to-treat’ diseases and GHD patients receive new drug
August 31 by Adam JeffsPharma IQ dives into advancements made in the field of drug discovery over the last week
Keeping tabs on Covid-19: EMA approves Moderna vaccine for teens and Japan approves Roche–Regeneron’s treatment
July 30 by Emily UwemedimoThe EMA recommends Moderna’s Covid-19 vaccine for 12–17 year olds as discussions continue with the FDA for approval for children in the US
Keeping tabs on pharma: DeepMind’s AI predicts the human proteome and Russia joins the trend of providing real-world evidence for clinical trials
July 26 by Adam JeffsA decade of research has been surpassed in just 15 minutes by AI and the availability of real-world evidence for clinical trials continues to grow